Exiqon A/S Releases New Advanced Bioinformatics Tools for Custom Design of MicroRNA Assays Based on Real-Time PCR and mRNA Assays by in Situ Hybridization

VEDBAEK, Denmark, Oct. 12, 2010 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ), a leading supplier of high-value gene expression analysis products, today announced the extension of the miRCURY LNA microRNA PCR product line with the launch of a novel bioinformatics software for the design of custom qPCR assays for microRNA quantification.
MORE ON THIS TOPIC